Peroxisome proliferator-activated receptor-α-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain

Endocrinology

Volumn 147, Issue 9, 2006, Pages 4067-4078

  Knauf, Claude ^a   Rieusset, Jennifer ^b   Foretz, Marc ^b   Cani, Patrice D ^a,d   Uldry, Marc ^b   Hosokawa, Masaya ^b   Martinez, Estelle ^a   Bringart, Matthieu ^a   Waget, Aurélie ^a   Kersten, Sander ^b   Desvergne, Béatrice ^b   Gremlich, Sandrine ^b   Wahli, Walter ^b   Seydoux, Josiane ^c   Delzenne, Nathalie M ^d   Thorens, Bernard ^b   Burcelin, Rémy ^a  

^a CNRS   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; MESSENGER RNA; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HYPOGLYCEMIA; INSULIN SENSITIVITY; LIPID STORAGE; LIVER CELL; LIVER METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS FAT; VIRUS RECOMBINANT; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BRAIN; CELL SIZE; FASTING; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEPATOCYTES; HYPOTHALAMUS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; PEROXISOME PROLIFERATORS; PPAR ALPHA; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33747586544     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1536     Document Type: Article

References (52)

1. Issemann I, Green S 1990 Activation of a member of the steroid hormone superfamily by peroxisome proliferators. Nature 347:645-650
2. Escher P, Wahli W 2000 Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448:121-138
3. Fruchart JC, Staels B, Duriez P 2001 PPARs, metabolic disease and atherosclerosis. Pharmacol Res 44:345-352
4. Kersten S, Desvergne B, Wahli W 2000 Roles of PPARs in health and disease. Nature 405:421-424
5. Hashimoto T, Cook W, Qi C, Yeldandi A, Reddy J, Rao M 2000 Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275:28918-28982
6. Minnich A, Tian N, Byan L, Bilder G 2001 A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle. Am J Physiol 280:E270-E279
7. Schoonjans K, Staels B, Auwerx J 1996 Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effect of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925
8. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ 1998 Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273:5678-5684
9. Kersten S, Seydoux J, Peters J, Gonzalez F, Desvergne B, Wahli W 1999 Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103:1489-1498
10. Patel D, Knight B, Wiggins D, Humphreys S, Gibbons G 2001 Disturbances in the normal regulation of SREBP-sensitive genes in PPARα-deficient mice. J Lipid Res 42:328-337
11. Chou CJ, Haluzik M, Gregory C, Dietz KR, Vinson C, Gavrilova O, Reitman ML 2002 WY14,643, a peroxisome proliferator-activated receptor α (PPARα) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J Biol Chem 277:24484-24489
12. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446
13. Boden G, Shulman GI 2002 Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and γ-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14-23
14. Ye JM, Iglesias MA, Watson DG, Ellis B, Wood L, Jensen PB, Sorensen RV, Larsen PJ, Cooney GJ, Wassermann K, Kraegen EW 2003 PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab 284:E531-E540
15. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW 2001 Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-γ activation. Diabetes 50:411-417
16. Haluzik M, Gavrilova O, LeRoith D 2004 Peroxisome proliferator-activated receptor-α deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies. Endocrinology 145:1662-1667
17. Mavri A, Bastelica D, Staels B, El Ayachi S, Juhan-Vague I, Alessi MC 2004 PPARα deficiency does not modify age dependency but prevents high fat diet increase in plasma PAI-1 as well as insulin resistance. Thromb Haemost 91:1051-1052
18. Guerre-Millo M, Rouault C, Poulain P, Andre J, Poitout V, Peters JM, Gonzalez FJ, Fruchart JC, Reach G, Staels B 2001 PPARα-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50:2809-2814
19. Kainu T, Wikstrom A, Gustafsson J, Pelto-Huikko M 1994 Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5:2481-2485
20. Cullingford TE, Dolphin CT, Sato H 2002 The peroxisome proliferator-activated receptor α-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacology 42:724-730
21. Cimini A, Cristiano L, Colafarina S, Benedetti E, Di Loreto S, Festuccia C, Amicarelli F, Canuto RA, Ceru MP 2005 PPARγ-dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF). Int J Cancer 117:923-933
22. Garcia-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC 2005 Peroxisome proliferator-activated receptor γ activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry 57:885-894
23. Lee JH, Joe EH, Jou I 2005 PPAR-α activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia. Neuroreport 16:829-833
24. Strakova N, Ehrmann J, Bartos J, Malikova J, Dolezel J, Kolar Z 2005 Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors. Neoplasma 52:126-136
25. Shimokawa T, Kumar MV, Lane MD 2002 Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc Natl Acad Sci USA 99:66-71
26. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B 2002 Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834-E842
27. Perrin C, Knauf C, Burcelin R 2004 Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145:4025-4033
28. Guillam M, Burcelin R, Thorens B 1998 Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci USA 95:12317-12321
29. Hosokawa M, Thorens B 2002 Glucose release from GLUT2-null hepatocytes: characterization of a major and a minor pathway. Am J Physiol 282:E794-E801
30. Burcelin R, Dolci W, Thorens B 2000 Portal glucose infusion in the mouse induces hypoglycemia. Evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49:1635-1642
31. Somogyi M 1945 Determination of blood sugar. J Biol Chem 160:69-73
32. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Liepvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, Foufelle F 1999ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19:3760-3768
33. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM 1994 Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359
34. Gremlich S, Nolan C, Roduit R, Burcelin R, Peyot ML, Delghingaro-Augusto V, Desvergne B, Michalik L, Prentki M, Wahli W 2005 Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor α transcriptional up-regulation of fatty acid oxidation. Endocrinology 146:375-382
35. Xu J, Xiao G, Trujillo C, Chang V, Blanco L, Joseph SB, Bassilian S, Saad MF, Tontonoz P, Lee WN, Kurland IJ 2002 Peroxisome proliferator-activated receptor α (PPARα) influences substrate utilization for hepatic glucose production. J Biol Chem 277:50237-50244
36. Gnudi L, Shepherd PR, Kahn BB 1996 Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: implications for nutrient partitioning. Proc Nutr Soc 55:191-199
37. Tozzo E, Gnudi L, Kahn BB 1997 Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138:1604-1611
38. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD 2005 Agonists for the peroxisome proliferator-activated receptor-α and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res 81:403-411
39. Postic C, Leturque A, Rencurel F, Printz RL, Forest C, Granner DK, Girard J 1993 The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue. Diabetes 42:922-929
40. Burcelin R, Kande J, Ricquier D, Girard J 1993 Changes in uncoupling protein and GLUT4 glucose transporter expressions in interscapular brown adipose tissue of diabetic rats: relative roles of hyperglycaemia and hypoinsulinaemia. Biochem J 291:109-113
41. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM 1999 PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617
42. Auwerx J 1999. PPARγ, the ultimate thrifty gene. Diabetologia 42:1033-1049
43. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI 2003 Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor α. J Biol Chem 278:48283-48291
44. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354-366
45. Chesnokova V, Melmed S 2002 Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143:1571-1574
46. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L 2001 Central melanocortin receptors regulate insulin action. J Clin Invest 108:1079-1085
47. Burcelin R, Uldry M, Foretz M, Perrin C, Dacosta A, Nenniger-Tosato M, Seydoux J, Cotecchia S, Thorens B 2004 Impaired glucose homeostasis in mice lacking the α1b-adrenergic receptor subtype. J Biol Chem 279:1108-1115
48. Obici S, Rossetti L 2003 Nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144:5172-5178
49. Obici S, Feng Z, Arduini A, Conti R, Rossetti L 2003 Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9:756-761
50. Liu L, Karkanias GB, Morales JC, Hawkins M, Barzilai N, Wang J, Rossetti L 1998 Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 273:31160-31167
51. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B 1996 Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia 39:353-356
52. Li G, Zhang Y, Wilsey JT, Scarpace PJ 2005 Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats. Diabetologia 48:2376-2385